Delivery Order SPE2DB22D3301-SPE2DB24FY2VA

Award Date 3/18/24
Potential Completion Date 4/8/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $7,322.67 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a delivery order contract with a firm fixed price pricing type, valued at $7,322.67, to provide Imbruvica 420 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the provision of IMBRUVICA 420 MG TABLET 28S, a prescription drug. The $43,936.02 firm fixed price delivery order has a completion date of July 29, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $14,645.34 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. This delivery order contract has a completion date of March 27, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and also holds a $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,322.67 firm fixed price delivery order is for the supply of 4,564,160,722 units of the prescription drug IMBRUVICA 420 MG TABLET 28S. This award is part of an indefinite delivery contract (IDC) valued up to $999,999,999.00 that serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $29,290.68 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the pharmaceutical product IMBRUVICA 140 MG TABLET 28S. This delivery order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product, with a potential value of $7,322.67. The order has a completion date of March 11, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has received numerous federal contract awards from DLA Troop Support Medical to supply...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 delivery order contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product. The contract is a firm fixed price, non-set-aside award with a performance period extending through June 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY2VA
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order placed by the Defense Logistics Agency (DLA) for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price of $7,322.67 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide. The contract does not have a set-aside designation.

Generated 6/17/24, 9:31 AM